Global Opisthorchiasis Treatment Market, By Type (Medications {Antibiotics, Anthelmintics, Others} v/s Surgery), By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others), By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, Competition Forecast and Opportunities, 2017-2027
The global opisthorchiasis treatment market is expected to grow at a significant rate during the forecast period. The market growth can be attributed to the rising incidences of infectious diseases caused by liver fluke and cat fluke among the global population. High demand for seafood due to their taste and nutritional value but lack of awareness about the parasitic infection caused by Opisthorchis Viverrini found in marine animals is boosting the growth of the global opisthorchiasis treatment market. Growing research and development activities for the early diagnosis and effective treatment options for diseases with advanced pharmaceutical products and surgical therapies. Prolonged infection exposure and the growing prevalence of chronic conditions in Asian countries like Thailand, Vietnam, Korea, and China are expected to fuel the growth of the global opisthorchiasis treatment market. Limited knowledge about the rules for disinfection of the local population and an increase in the number of amateur fishermen and poachers are contributing to the growing incidences of opisthorchiasis, which is propelling the growth of the global opisthorchiasis treatment market. Increasing awareness about the environmental depletion due to contamination of water sources in ocean and water bodies by untreated waste dump are further aiding to the rising infection in marine life, contributing to the growing liver infections among the global population. As people across the globe are increasingly becoming aware of the diseases and their available treatments, the demand for healthcare services and treatments is booming at an exponential rate. Moreover, the growing number of healthcare facilities, the emergence of new technologies, and rising innovation are expected to fuel the growth of the global opisthorchiasis treatment market during the forecast period.
The global opisthorchiasis treatment market is segmented on the basis on type, diagnostic procedure, symptom, end user, regional distribution, and competitive landscape. Based on diagnostic procedure, the market is divided into Cholangiography, MRI, Ultrasonography, CT scan, and others. The Cholangiography segment is expected to hold the largest share in the global opisthorchiasis treatment market due to the standardization of stool examination. Based on end-user, the market is fragmented into hospitals & clinics, ambulatory care centres, and others. The hospitals & clinics segment is anticipated to dominate the global opisthorchiasis treatment market as they provide better medical equipment, products, and services to the patients.
Major players operating in the global opisthorchiasis treatment market include Cipla Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Merck KGaA, Boehringer Ingelheim International GmbH, Pfizer Inc., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., AbbVie Inc., Mankind Pharma Limited, among others.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022E
Forecast Period: 2023F–2027F
Objective of the Study:
- To analyze the historical growth in the market size of global opisthorchiasis treatment market from 2017 to 2021.
- To estimate and forecast the market size of global opisthorchiasis treatment market from 2022E to 2027F and growth rate until 2027F.
- To classify and forecast global opisthorchiasis treatment market based on type, diagnostic procedure, symtom, end user, region, and competitive landscape.
- To identify dominant region or segment in the global opisthorchiasis treatment market.
- To identify drivers and challenges for global opisthorchiasis treatment market.
- To examine competitive developments such as expansions, new services, mergers & acquisitions, etc., in global opisthorchiasis treatment market.
- To identify and analyze the profile of leading players operating in global opisthorchiasis treatment market.
- To identify key sustainable strategies adopted by market players in global opisthorchiasis treatment market.
In this report, global opisthorchiasis treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Opisthorchiasis Treatment Market, By Type:
- Medications
- Antibiotics
- Anthelmintics
- Others
- Surgery
- Opisthorchiasis Treatment Market, By Diagnostic Procedure:
- Cholangiography
- MRI
- Ultrasonography
- CT scan
- Others
- Opisthorchiasis Treatment Market, By Symptom:
- Jaundice
- Diarrhea
- Fever
- Splenomegaly
- Weight loss
- Tachycardia
- Others
- Opisthorchiasis Treatment Market, By End User:
- Hospitals & Clinics
- Ambulatory Care Centers
- Others
- Opisthorchiasis Treatment Market, By Region:
- North America
- United States
- Mexico
- Canada
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- South America
- Brazil
- Argentina
- Colombia
TechSci Research calculated the market size of the global opisthorchiasis treatment market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these treatment types for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Opisthorchiasis treatment service provider companies/partners
- End-Users
- Government bodies such as regulating authorities and policy makers
- Organizations, industry associations, forums and alliances related to global opisthorchiasis treatment market
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global opisthorchiasis treatment market.
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
- 1. Service Overview
- 2. Research Methodology
- 3. Executive Summary
- 4. Impact of COVID-19 on Global Opisthorchiasis Treatment Market
- 5. Voice of Customer
- 5.1. Prevalence, By Geography
- 5.2. Prevalence, By Gender
- 5.3. Commonly Observed Symptoms
- 5.4. Preferred Choice of Treatment
- 6. Global Opisthorchiasis Treatment Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Type (Medications v/s Surgery)
- 6.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
- 6.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
- 6.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
- 6.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
- 6.2.5. By Company (2021)
- 6.2.6. By Region
- 6.3. Market Map
- 7. North America Opisthorchiasis Treatment Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Type (Medications v/s Surgery)
- 7.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
- 7.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
- 7.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
- 7.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
- 7.2.5. By Country
- 7.3. North America: Country Analysis
- 7.3.1. United States Opisthorchiasis Treatment Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Type
- 7.3.1.2.2. By Diagnostic Procedure
- 7.3.1.2.3. By Symptom
- 7.3.1.2.4. By End User
- 7.3.2. Mexico Opisthorchiasis Treatment Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Type
- 7.3.2.2.2. By Diagnostic Procedure
- 7.3.2.2.3. By Symptom
- 7.3.2.2.4. By End User
- 7.3.3. Canada Opisthorchiasis Treatment Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Type
- 7.3.3.2.2. By Diagnostic Procedure
- 7.3.3.2.3. By Symptom
- 7.3.3.2.4. By End User
- 8. Europe Opisthorchiasis Treatment Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Type (Medications v/s Surgery)
- 8.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
- 8.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
- 8.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
- 8.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
- 8.2.5. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. France Opisthorchiasis Treatment Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Type
- 8.3.1.2.2. By Diagnostic Procedure
- 8.3.1.2.3. By Symptom
- 8.3.1.2.4. By End User
- 8.3.2. Germany Opisthorchiasis Treatment Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Type
- 8.3.2.2.2. By Diagnostic Procedure
- 8.3.2.2.3. By Symptom
- 8.3.2.2.4. By End User
- 8.3.3. United Kingdom Opisthorchiasis Treatment Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Type
- 8.3.3.2.2. By Diagnostic Procedure
- 8.3.3.2.3. By Symptom
- 8.3.3.2.4. By End User
- 8.3.4. Italy Opisthorchiasis Treatment Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Type
- 8.3.4.2.2. By Diagnostic Procedure
- 8.3.4.2.3. By Symptom
- 8.3.4.2.4. By End User
- 8.3.5. Spain Opisthorchiasis Treatment Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Type
- 8.3.5.2.2. By Diagnostic Procedure
- 8.3.5.2.3. By Symptom
- 8.3.5.2.4. By End User
- 9. Asia-Pacific Opisthorchiasis Treatment Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Type (Medications v/s Surgery)
- 9.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
- 9.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
- 9.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
- 9.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
- 9.2.5. By Country
- 9.3. Asia-Pacific: Country Analysis
- 9.3.1. China Opisthorchiasis Treatment Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Type
- 9.3.1.2.2. By Diagnostic Procedure
- 9.3.1.2.3. By Symptom
- 9.3.1.2.4. By End User
- 9.3.2. India Opisthorchiasis Treatment Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Type
- 9.3.2.2.2. By Diagnostic Procedure
- 9.3.2.2.3. By Symptom
- 9.3.2.2.4. By End User
- 9.3.3. South Korea Opisthorchiasis Treatment Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Type
- 9.3.3.2.2. By Diagnostic Procedure
- 9.3.3.2.3. By Symptom
- 9.3.3.2.4. By End User
- 9.3.4. Japan Opisthorchiasis Treatment Market Outlook
- 9.3.4.1. Market Size & Forecast
- 9.3.4.1.1. By Value
- 9.3.4.2. Market Share & Forecast
- 9.3.4.2.1. By Type
- 9.3.4.2.2. By Diagnostic Procedure
- 9.3.4.2.3. By Symptom
- 9.3.4.2.4. By End User
- 9.3.5. Australia Opisthorchiasis Treatment Market Outlook
- 9.3.5.1. Market Size & Forecast
- 9.3.5.1.1. By Value
- 9.3.5.2. Market Share & Forecast
- 9.3.5.2.1. By Type
- 9.3.5.2.2. By Diagnostic Procedure
- 9.3.5.2.3. By Symptom
- 9.3.5.2.4. By End User
- 10. South America Opisthorchiasis Treatment Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Type (Medications v/s Surgery)
- 10.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
- 10.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
- 10.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
- 10.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
- 10.2.5. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Opisthorchiasis Treatment Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Type
- 10.3.1.2.2. By Diagnostic Procedure
- 10.3.1.2.3. By Symptom
- 10.3.1.2.4. By End User
- 10.3.2. Argentina Opisthorchiasis Treatment Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Type
- 10.3.2.2.2. By Diagnostic Procedure
- 10.3.2.2.3. By Symptom
- 10.3.2.2.4. By End User
- 10.3.3. Colombia Opisthorchiasis Treatment Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Type
- 10.3.3.2.2. By Diagnostic Procedure
- 10.3.3.2.3. By Symptom
- 10.3.3.2.4. By End User
- 11. Middle East and Africa Opisthorchiasis Treatment Market Outlook
- 11.1. Market Size & Forecast
- 11.1.1. By Value
- 11.2. Market Share & Forecast
- 11.2.1. By Type (Medications v/s Surgery)
- 11.2.1.1. By Medications (Antibiotics, Anthelmintics, Others)
- 11.2.2. By Diagnostic Procedure (Cholangiography, MRI, Ultrasonography, CT scan, Others)
- 11.2.3. By Symptom (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Others)
- 11.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
- 11.2.5. By Country
- 11.3. MEA: Country Analysis
- 11.3.1. South Africa Opisthorchiasis Treatment Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.1.1. By Value
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Type
- 11.3.1.2.2. By Diagnostic Procedure
- 11.3.1.2.3. By Symptom
- 11.3.1.2.4. By End User
- 11.3.2. Saudi Arabia Opisthorchiasis Treatment Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.1.1. By Value
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Type
- 11.3.2.2.2. By Diagnostic Procedure
- 11.3.2.2.3. By Symptom
- 11.3.2.2.4. By End User
- 11.3.3. UAE Opisthorchiasis Treatment Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.1.1. By Value
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Type
- 11.3.3.2.2. By Diagnostic Procedure
- 11.3.3.2.3. By Symptom
- 11.3.3.2.4. By End User
- 12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
- 13. Market Trends & Developments
- 14. Competitive Landscape
- 14.1. Cipla Inc.
- 14.2. Johnson & Johnson
- 14.3. Sun Pharmaceutical Industries Ltd.
- 14.4. Merck KGaA
- 14.5. Boehringer Ingelheim International GmbH
- 14.6. Pfizer Inc.
- 14.7. GlaxoSmithKline plc
- 14.8. F. Hoffmann-La Roche Ltd
- 14.9. AbbVie Inc
- 14.10. Mankind Pharma Limited
- 15. Strategic Recommendations
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook